SK

Suneel Kumar Guntupalli

Active Director Director DIN 07311964
DIN 07311964 First appointment Dec 2015 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 1 historical roles
Total affiliations 4 Since Dec 2015
Shareholding value •••• Premium profile

About Suneel Kumar Guntupalli

Data last updated:

Suneel Kumar Guntupalli is a Director at Raveez Pharma Private Limited (since 2021), Director at Tarak Securities Private Limited (since 2021) and Cfo at Narmadaria Laboratories Private Limited (since 2017). The companies operate in Pharma and Financial Services. The largest current company by reported revenue is Raveez Pharma Private Limited at ₹19.14 Cr (FY 2025). Earlier, Suneel Kumar Guntupalli was a Director at Yaadaadri Life Sciences Private Limited (from 2015).

DIN 07311964
Primary Designation Director
Industry Pharma
First Appointment 18 Dec 2015
Oldest Company Age 10 yrs
Largest company Raveez Pharma Private Limited · ₹19.14 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Raveez Pharma Private Limited U24299TG2021PTC155832
Director11 Oct 20212021₹19.14 Cr (FY 2025)Active
Tarak Securities Private Limited U65900TG2021PTC155989
Director14 Oct 20212021Active
Cfo20 Sep 20172017Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 Dec 20152015Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Yaadaadri Life Sciences Private Limited
Raveez Pharma Private Limited
Narmadaria Laboratories Private Limited
Tarak Securities Private Limited
Premium access

Shareholding and investment profile for Suneel Kumar Guntupalli

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suneel Kumar Guntupalli

Suneel Kumar Guntupalli currently holds 3 directorships: Raveez Pharma Private Limited (Director, since 11 Oct 2021, revenue ₹19.14 Cr (FY 2025)); Tarak Securities Private Limited (Director, since 14 Oct 2021); Narmadaria Laboratories Private Limited (Cfo, since 20 Sep 2017).

Suneel Kumar Guntupalli was first appointed on 18 Dec 2015 as Director at Yaadaadri Life Sciences Private Limited. The most recent appointment on record is 14 Oct 2021 at Tarak Securities Private Limited.

Suneel Kumar Guntupalli held 1 earlier board appointment: Yaadaadri Life Sciences Private Limited (Director, from 18 Dec 2015).

The current boards of Suneel Kumar Guntupalli's companies include Hari Shankar Dhanturi (Raveez Pharma Private Limited), Mamatha Dhanturi (Raveez Pharma Private Limited), Radha Krishna Gadiparthi (Raveez Pharma Private Limited), Ravinder Dhanturi (Raveez Pharma Private Limited), Koteswari Guntupalli (Tarak Securities Private Limited), Sudheer Guntupalli (Tarak Securities Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available